Brown-Forman (BF.B) earnings estimates were updated after reporting fourth quarter results, said UBS. FY13 EPS was reduced by $0.02 to $2.70 and FY14 EPS was increased by $0.04 to $3.14. Based on the new FY14 EPS estimate, the price target was increased to $75, said UBS.
Impax Labs (IPXL) earnings estimates were reduced, said UBS. A new 483 warning letter had a lot more extensive issues, leading to uncertainty, said UBS. Price target was reduced to $17.
Newcastle Investment (NCT) earnings estimates were increased through 2014 after reporting fourth quarter results, said UBS. The update includes the announcement to acquire a 50% interest in a consumer loan portfolio from HSBC, said UBS. Price target increased to $14.
Staples (SPLS) earnings estimates through FY2014 were reduced after reporting fourth quarter results, said UBS. Aggressive sales guidance leads to uncertainty and the ODP/OMX merger will over shadow the stock, said UBS. Price target remains $13.Shares of Time Warner (TWX) now seen reaching $61, according to Credit Suisse. Spin-off of the publishing unit should help unlock value, according to Credit Suisse. Outperform rating. Exxon Mobil (XOM) earnings estimates were reduced, said UBS. The company provided a weaker than expected production outlook at its analysts meeting, said UBS. Price target remains $91. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.